dc.date.accessioned2019-01-25T16:36:29Z
dc.date.available2019-01-25T16:36:29Z
dc.date.created2019-01-25T16:36:29Z
dc.date.issued2017
dc.identifierhttps://hdl.handle.net/20.500.12866/4853
dc.identifierhttps://doi.org/10.1371/journal.pone.0173581
dc.description.abstractIntroduction: Type III Bartter syndrome (BS) is an autosomal recessive renal tubule disorder caused by loss-of-function mutations in the CLCNKB gene, which encodes the chloride channel protein ClC-Kb. In this study, we carried out a complete clinical and genetic characterization in a cohort of 30 patients, one of the largest series described. By comparing with other published populations, and considering that 80% of our patients presented the p. Ala204Thr Spanish founder mutation presumably associated with a common phenotype, we aimed to test the hypothesis that allelic differences could explain the wide phenotypic variability observed in patients with type III BS. Methods: Clinical data were retrieved from the referral centers. The exon regions and flanking intronic sequences of the CLCNKB gene were screened for mutations by polymerase chain reaction (PCR) followed by direct Sanger sequencing. Presence of gross deletions or duplications in the region was checked for by MLPA and QMPSF analyses. Results: Polyuria, polydipsia and dehydration were the main common symptoms. Metabolic alkalosis and hypokalemia of renal origin were detected in all patients at diagnosis. Calciuria levels were variable: hypercalciuria was detected in 31% of patients, while 23% had hypocalciuria. Nephrocalcinosis was diagnosed in 20% of the cohort. Two novel CLCNKB mutations were identified: a small homozygous deletion (c.753delG) in one patient and a small deletion (c.1026delC) in another. The latter was present in compound heterozygosis with the already previously described p.Glu442Gly mutation. No phenotypic association was obtained regarding the genotype. Conclusion: A poor correlation was found between a specific type of mutation in the CLCNKB gene and type III BS phenotype. Importantly, two CLCNKB mutations not previously described were found in our cohort.
dc.languageeng
dc.publisherPublic Library of Science
dc.relationPLoS ONE
dc.relation1932-6203
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectScience & Technology - Other Topics
dc.subjectchloride channel gene
dc.subjectclcnkb
dc.subjectgitelman
dc.subjectmolecular analysis
dc.subjectmutations
dc.subjectnephrocalcinosis
dc.subjectsalt-losing tubulopathies
dc.titlePoor phenotype-genotype association in a large series of patients with Type III Bartter syndrome
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución